The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: A prospective clinical study

European Journal of Gynaecological Oncology

Volumn 30, Issue 3, 2009, Pages 303-308

  Ozmen B ^a,b   Duvan, C I ^a   Gumus G ^a   Sonmezer M ^a   Gungor, M ^a   Ortac F ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b University of Fatih School of Medicine ^*  (Turkey)

Author keywords

First line chemotherapy; Primary epithelial ovarian cancer; Recurrence; Telomerase activity; TRAP assay

Indexed keywords

TELOMERASE;

ADULT; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; EPITHELIAL OVARIAN CANCER; FEMALE; HUMAN; OVARY CANCER; SENSITIVITY AND SPECIFICITY;

ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 67649800380     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sonmezer M., Gungor M., Ensari A., Ortac F.: "Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor". Int. J. Gynecol. Cancer, 2004, 14, 82. (Pubitemid 38280627)
2. Adib T.R., Henderson S., Perrett C., Hewitt D., Bourmpoulia D., Ledermann J., Boshoff C.: "Predicting biomarkers for ovarian cancer using gene-expression microarrays". Br. J. Cancer, 2004, 90, 686. (Pubitemid 38297211)
3. Cech T.R.: "Beginning to understand the end of the chromosome". Cell., 2004, 116, 273.
4. Kim N.W., Piatyszek M.A., Prowse K.R.: "Spesific association of human telomerase activity with immortal cells and cancer". Science, 1994, 266, 2011.
5. Shay J.W., Bacchetti S.: "A survey of telomerase activity in human cancer". Eur. J. Cancer, 1997, 33, 787. (Pubitemid 27239490)
6. Hiyama E., Gollahon L., Kataoka T.: "Telomeric activity in breast tumors". J. Natl. Cancer Inst., 1996, 88, 116.
7. Hiyama E., Kodama T., Shinbara K.: "Telomerase activity is detected in pancreatic cancer but not in benign tumors". Cancer Res., 1997, 57, 326. (Pubitemid 27036614)
8. Hiyama E., Hiyama K., Tatsumoto N., Shay J.W., Yokoyama T.: "Telomerase activity in human intestine". Int. J. Oncol., 1996, 9, 453. (Pubitemid 26323934)
9. Sakamoto M., Toyoizumi T., Kikuchi Y., Okamoto A., Nakayama H., Aoki D. et al.: "Telomerase activity in gynecological tumors". Oncol. Rep., 2000, 7, 1003.
10. Zheng P.S., Iwasaka T., Yamasaki F., Ouchida M., Yokoyama M., Nakao Y. et al.: "Telomerase activity in gynecologic tumors". Gynecol. Oncol., 1997, 64, 171. (Pubitemid 27026978)
11. Datar R.H., Naritoku W.Y., Li P., Tsao-Wei D., Groshen S., Taylor C.R., Imam S.A.: "Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas". Oncol., 1999, 74, 338.
12. Kyo S., Kanaya T., Takakura M., Tanaka M., Yamashita A., Inoue H., Inoue M.: "Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors". Int. J. Cancer, 1999, 80, 804. (Pubitemid 29108852)
13. Hiyama E., Hiyama K.: "Telomerase as tumor marker". Cancer Lett., 2003, 15, 221.
14. Langford L.A., Piatyszek M.A., Xu R., Schold S.C., Wright W.E., Shay J.W.: "Telomerase activity in ordinary meningiomas predicts poor outcome". Human. Pathol., 1997, 28, 416. (Pubitemid 27175081)
15. Zhang W., Piatyszek M.A., Kobayashi T.: "Telomerase activity in human acute myelogenous leukemia: inhibition of TA by differantiation-inducing agents". Clin. Cancer Res., 1996, 2, 799. (Pubitemid 26169989)
16. Dowdy S.C., O'Kane D.J., Keeney G.L., Boyd J., Podratz K.C.: "Telomerase activity in sex cord-stromal tumors of the ovary". Oncol., 2001, 82, 257.
17. Shi-Jun Wang, Sakamoto T., Yasuda S., Fukasawa I., Ota Y., Hayashi M., Okura T., Zheng J.H., Inaba N.: "The relationship between telomere length and telomerase activity in gynecologic tumors". Gynecol. Oncol., 2002, 84, 81.
18. Cardozo P.L.: "A critical evaluation of 3000 cytologic analysis of pleural fluid, acsitic fluid and pericardial fluid". Acta Cytol., 1996, 10, 455.
19. Tseng C.J., Jain S., Hou H.C., Liu W., Pao C.C., Lin C.T., Horng S.G., Soong Y.K., Hsueh S.: "Applications of the telomerase assay in peritoneal washing fluids". Gynecol. Oncol., 2001, 81, 420. (Pubitemid 32496292)
20. th edition, St. Louis, Mosby-Year Book, 1997, 282.
21. nd edition, New York, John Wiley & Sons, 1980, 5, 229.
22. Rose P.G., Faulhaber P., Miraldi F., Abdul-Karim F.W.: "Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy". Gynecol. Oncol., 2001, 82, 17. (Pubitemid 32634948)
23. Wisman G.B., Hollema H., Helder M.N., Knol A.J., Van der Meer G.T., Krans M. et al.: "Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours". Int. J. Oncol., 2003, 23, 1451.
24. Baykal A., Thompson J.A., Xu X.C. et al.: "In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues". Oncol. Rep., 2004, 11, 297.
25. Wada Y., Yagihashi A., Kameshima H., Matsuura A., Sato N., Kikuchi K. et al.: "Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe". Immunopharmacol. Immunotoxicol., 1997, 19, 451. (Pubitemid 28112596)
26. Duggan B.D., Wan M., Yu M.C., Roman L.D., Muderspach L.I., Delgadillo E. et al.: "Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination". Cancer Inst., 1998, 90, 238.
27. Ohwada M., Suzuki M., Suzuki T., Hiratsuka M., Kawai T., Saito K., Sato I.: "Problems with peritoneal cytology in second-look laparotomy performed in patients with epithelial ovarian carcinoma". Cancer, 2001, 93, 376. (Pubitemid 34019637)
28. Yashima K., Piatyszek M.A., Saboorian H.M.: "Telomerase activity and in situ telomerase RNA expression in malignant and nonmalignant lymph nodes". J. Clin. Pathol., 1997, 50, 110. (Pubitemid 27093025)
29. Nouriani M., Bahador A., Berek J.S., Cheng J.P., Chi D.S., Cliby W.A. et al.: "Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy". Clin. Cancer Res., 2004, 10, 2681. (Pubitemid 38509142)
30. Gisselsson D., Lv M., Tsao S.W. et al.: "Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma". Genes Chromosomes Cancer, 2005, 42, 22. (Pubitemid 39578662)
31. Landen C.N., Klingelhutz A., Coffin J.E. et al.: "Genomic instability is associated with lack of telomerase activation in ovarian cancer". Cancer Biol. Ther., 2004, 3, 1250. (Pubitemid 41350961)
32. Li D.J., Zhang Y.Z., Zhang D.H.: "Activity of telomerase and extracellular regulated protein kinases in parental and drug resistant cells of leukemia and ovarian cancer". Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2004, 12, 304.
33. Park T.W., Riethdorf S., Riethdorf L. et al.: "Differential TA, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors". Int. J. Cancer, 1999, 84, 426. (Pubitemid 29337132)